Methods: The study enrolled 113 symptomatic patients who had carotid artery stenosis ≥50% according to the North American Symptomatic Carotid Endarterectomy Trial criteria with a history of a recent transient ischemic attack or partially recovered cerebrovascular accidents between June 2011 and June 2014. The patients were able to carry on with their daily activities on their own. The control group consisted of 114 patients who did not meet these criteria. All blood samples were obtained after 12 hours of fasting. The red cell distribution width values of the study group and the controls were compared. The red cell distribution width values were also assessed in terms of the possible relation with cardiovascular risk factors and clinical features in the study group.
Results: There was no significant association between the red cell distribution width values and carotid artery stenosis in the study group. The red cell distribution width did not reach significance among the study patients with respect to the preoperative and postoperative clinical features.
Conclusion: Although increased red cell distribution width values may be considered as an epiphenomenon due to an underlying biological or metabolic imbalance, it still necessitates further comprehensive studies to conclude that it is an independent cardiovascular risk factor for carotid artery disease.
In this study, we aimed to investigate whether the RDW is an independent cardiovascular risk factor for CAS in patients undergoing carotid endarterectomy (CEA).
This study included a total of 113 patients who were operated either unilaterally or bilaterally between June 2011 and June 2014 with ≥50% stenosis in their unilateral or bilateral carotid arteries according to the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria. The patients referred from the neurology department were those who had a history of a transient ischemic attack (TIA) or partially irreversible neurological deficits (IND) recovered from a cerebrovascular event, but who were able to carry on with their daily activities on their own. The preliminary examination was performed by Doppler ultrasonography, while the definitive diagnosis was made by cervical computed tomography or magnetic resonance angiographies. There were a total of 114 patients in the control group who did not have any neurological problems either clinically or radiologically with no stenosis or plaques in their carotid arteries, and whose peak systolic velocities were <100 cm/sec. The patients with a blood pressure of >140/90 mmHg, those receiving oral anti-hypertensive drugs or those who were diagnosed with a high blood pressure by the treating physician were accepted as hypertensives. The patients who were diagnosed with a high blood glucose level using oral anti-diabetic drugs or insulin with a hemoglobin A1c levels of 6.5% were accepted as diabetics. The patients with a total serum cholesterol level of 240 mg/dL receiving anti-lipidemic drugs were accepted as hyperlipidemics. The patients with a body mass index (BMI) of 30 were accepted as obese patients. As preparations for the CEA operations were carried out, all patients were routinely investigated in terms of CHD. A coronary angiography was undertaken when necessary. A written informed consent was obtained from each patient.
All operations were accomplished under general anesthesia with the patients heparinized without the use of a shunt by the surgeon who carries out more than 30 CEA operations annually. All patients had a saphenous vein patch for the closure of the arteriotomy following CEA. Following surgery, they were all examined by a neurologist for any newly developed neurological deficits. We operated all patients within one month following the cerebrovascular events. The patients who had bilateral carotid stenoses were operated in separate sessions. The patients who had hepatic, renal or cardiac failures, those with a diagnosis of malignancy, those with inflammatory diseases, and undergoing simultaneous CEA and coronary artery bypass grafting were excluded. All data including demographic and clinical characteristics and complete blood count test results were obtained from the hospital database.
Blood samples were obtained from the study patients during the preoperative preparation period following a 12 hours fasting period, while blood samples for the controls were taken at the outpatient ward at 08.00 AM after the same fasting period. All biochemical variables were studied from the serum of the blood samples by using the Abbott Architect C8000 analyzer (Abbott Laboratories, Abbott Park, IL, USA), and hematological parameters were studied from the blood samples taken into the tubes containing ethylenediaminetetraacetic acid (EDTA) using an automatic blood counter (System XT-2000i, Roche Diagnostics, Indianapolis, IN, USA). Based on the institutional laboratory reference ranges (11.6% to 14.8%), we reported red blood cell volume as a coefficient of variation (percentage).
Statistical analysis
Statistical analysis was performed using the
MedCalc for Windows, version 15.0 (MedCalc
Software, Ostend, Belgium) and PASW Statistics
for Windows, version 18.0 (SPSS Inc., Chicago, IL,
USA) software. Categorical variables were presented
in percentages and frequencies, while the odds ratios
were expressed at their significance level. Parametric
methods were used due to the large sample size.
Descriptive statistics were given in mean and standard
deviation. Independent sample t tests were used to
compare the means of dependent groups. Despite small
sample size, an intragroup analysis was also performed
for the patients only with CAS and the patients with
coexistent CHD, bilateral carotid stenosis, bleeding or
hematoma. As a result, the number of this subgroup was
balanced with the mere carotid group by increasing the
group count 1.5 fold.
Therefore, the lack of a decisive value of RDW in our study can be explained by the mild ischemic attacks in our study population. On the other hand, some studies showing the relationship between the RDW and risk factors and atherosclerosis also yielded conflicting results. In the literature, significantly higher RDW values were found in the study groups of reports showing the close relationship between the RDW and atherosclerotic risk factors.[2,4,6] However, Chen at al.[18] reported that they were unable to establish a definite correlation between the RDW and CHD, despite significantly high atherosclerotic risk factors in their study group. In another study reporting controversial results between the RDW, stroke severity, and functional termination of the stroke, the authors also showed no correlation between other risk factors and atherosclerotic risk factors.[19] Altogether, we can conclude that the correlation between the RDW values, atherosclerosis, and other risk factors is not evident.
On the other hand, our study has some limitations. The relatively small sample of study subjects may have affected the results. In addition, large-scale prospective randomized studies are required to establish a definite conclusion.
In conclusion, although increased red cell distribution width values may be considered as an epiphenomenon due to an underlying biological or metabolic imbalance, it still necessitates further comprehensive studies to conclude that it is an independent cardiovascular risk factor for carotid artery disease.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
1) Veeranna V, Zalawadiya SK, Panaich S, Patel KV, Afonso
L. Comparative analysis of red cell distribution width and
high sensitivity C-reactive protein for coronary heart disease
mortality prediction in multi-ethnic population: findings from
the 1999-2004 NHANES. Int J Cardiol 2013;168:5156-61.
2) Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik
JM. Red blood cell distribution width and the risk of
death in middle-aged and older adults. Arch Intern Med
2009;169:515-23.
3) Skjelbakken T, Lappegård J, Ellingsen TS, Barrett-Connor
E, Brox J, Løchen ML, et al. Red cell distribution width is
associated with incident myocardial infarction in a general
population: the Tromsø Study. J Am Heart Assoc 2014;3.
4) Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP,
Wallace RB, et al. Red cell distribution width and mortality
in older adults: a meta-analysis. J Gerontol A Biol Sci Med
Sci2010;65:258-65.
5) Söderholm M, Borné Y, Hedblad B, Persson M, Engström G.
Red cell distribution width in relation to incidence of stroke
and carotid atherosclerosis: a population-based cohort study.
PLoS One 2015;10:0124957.
6) Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray
JJ, Pfeffer MA, et al. Red cell distribution width as a novel
prognostic marker in heart failure: data from the CHARM
Program and the Duke Databank. J Am Coll Cardiol
2007;50:40-7.
7) Borné Y, Smith JG, Melander O, Hedblad B, Engström G.
Red cell distribution width and risk for first hospitalization
due to heart failure: a population-based cohort study. Eur J
Heart Fail 2011;13:1355-61.
8) Jia H, Li H, Zhang Y, Li C, Hu Y, Xia C. Association between
red blood cell distribution width (RDW) and carotid artery
atherosclerosis (CAS) in patients with primary ischemic
stroke. Arch Gerontol Geriatr 2015;61:72-5.
9) Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo
M, Sharrett AR, et al. Association of coronary heart disease
incidence with carotid arterial wall thickness and major risk
factors: the Atherosclerosis Risk in Communities (ARIC)
Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
10) Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu
CH, et al. The role of carotid arterial intima-media thickness
in predicting clinical coronary events. Ann Intern Med
1998;128:262-9.
11) Rosvall M, Janzon L, Berglund G, Engström G, Hedblad
B. Incidence of stroke is related to carotid IMT even in the
absence of plaque. Atherosclerosis 2005;179:325-31.
12) Touboul PJ, Labreuche J, Vicaut E, Amarenco P. Carotid
intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke
2005;36:1741-5.
13) Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD,
Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/
ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on
the management of patients with extracranial carotid and
vertebral artery disease: a report of the American College
of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines, and the American
Stroke Association, American Association of Neuroscience
Nurses, American Association of Neurological Surgeons,
American College of Radiology, American Society of
Neuroradiology, Congress of Neurological Surgeons, Society
of Atherosclerosis Imaging and Prevention, Society for
Cardiovascular Angiography and Interventions, Society of
Interventional Radiology, Society of NeuroInterventional
Surgery, Society for Vascular Medicine, and Society for
Vascular Surgery. J Am Coll Cardiol 2011;57:16-94.
14) Ani C, Ovbiagele B. Elevated red blood cell distribution
width predicts mortality in persons with known stroke. J Neurol Sci 2009;277:103-8.
15) Ramírez-Moreno JM, Gonzalez-Gomez M, Ollero-Ortiz A,
Roa-Montero AM, Gómez-Baquero MJ, Constantino-Silva
AB. Relation between red blood cell distribution width and
ischemic stroke: a case-control study. Int J Stroke 2013;8:36.
16) Kim J, Kim YD, Song TJ, Park JH, Lee HS, Nam CM,
et al. Red blood cell distribution width is associated with
poor clinical outcome in acute cerebral infarction. Thromb
Haemost 2012;108:349-56.
17) Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru
A. Red cell distribution width and neurological scoring
systems in acute stroke patients. Neuropsychiatr Dis Treat
2015;11:733-9.